دورية أكاديمية
Safety of the PCSK9 inhibitor alirocumab: insights from 47 296 patient-years of observation.
| العنوان: | Safety of the PCSK9 inhibitor alirocumab: insights from 47 296 patient-years of observation. |
|---|---|
| المؤلفون: | Goodman SG; Canadian VIGOUR Centre, University of Alberta, Edmonton, Alberta, Canada.; St. Michael's Hospital, University of Toronto, Toronto, Ontario, Canada., Steg PG; Université Paris-Cité, Institut Universitaire de France, Assistance Publique-Hôpitaux de Paris, Hôpital Bichat, FACT (French Alliance for Cardiovascular Trials), and INSERM U1148, F-75018 Paris, France., Szarek M; CPC Clinical Research and Division of Cardiology, University of Colorado School of Medicine, Aurora, 80045 CO, USA.; State University of New York, Downstate Health Sciences University, Brooklyn, NY 11203, USA., Bhatt DL; Mount Sinai Heart, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA., Bittner VA; Division of Cardiovascular Disease, University of Alabama at Birmingham, Birmingham, AL 35233, USA., Diaz R; Estudios Cardiológicos Latinoamérica, Instituto Cardiovascular de Rosario, S2000 Rosario, Argentina., Harrington RA; Cornell University, New York, NY 10065, USA., Jukema JW; Department of Cardiology, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands.; Netherlands Heart Institute, 3511 EP Utrecht, The Netherlands., White HD; Green Lane Cardiovascular Research Unit, Te Whatu Ora-Health New Zealand, Te Toka Tumai, and University of Auckland, Auckland 1030, New Zealand., Zeiher AM; Department of Medicine III, Goethe University, 60596 Frankfurt am Main, Germany., Manvelian G; Regeneron Pharmaceuticals Inc., Tarrytown, NY 10591, USA., Pordy R; Regeneron Pharmaceuticals Inc., Tarrytown, NY 10591, USA., Poulouin Y; IT&M Stats, Neuilly-sur-Seine 92200, France., Stipek W; Regeneron Pharmaceuticals Inc., Tarrytown, NY 10591, USA., Garon G; Sanofi, Toronto, ON M2R 3T4, Canada., Schwartz GG; University of Colorado School of Medicine, Aurora 80045, CO, USA. |
| مؤلفون مشاركون: | ODYSSEY OUTCOMES Investigators |
| المصدر: | European heart journal. Cardiovascular pharmacotherapy [Eur Heart J Cardiovasc Pharmacother] 2024 Jul 16; Vol. 10 (4), pp. 342-352. |
| نوع المنشور: | Journal Article; Review |
| اللغة: | English |
| بيانات الدورية: | Publisher: Oxford University Press Country of Publication: England NLM ID: 101669491 Publication Model: Print Cited Medium: Internet ISSN: 2055-6845 (Electronic) NLM ISO Abbreviation: Eur Heart J Cardiovasc Pharmacother Subsets: MEDLINE |
| أسماء مطبوعة: | Original Publication: Oxford : Oxford University Press, [2015]- |
| مواضيع طبية MeSH: | Antibodies, Monoclonal, Humanized*/adverse effects , Antibodies, Monoclonal, Humanized*/therapeutic use , Cholesterol, LDL*/blood , PCSK9 Inhibitors*, Humans ; Anticholesteremic Agents/adverse effects ; Anticholesteremic Agents/therapeutic use ; Biomarkers/blood ; Cardiovascular Diseases/prevention & control ; Cardiovascular Diseases/mortality ; Cardiovascular Diseases/diagnosis ; Cardiovascular Diseases/blood ; Dyslipidemias/drug therapy ; Dyslipidemias/blood ; Dyslipidemias/diagnosis ; Proprotein Convertase 9/metabolism ; Proprotein Convertase 9/immunology ; Randomized Controlled Trials as Topic ; Serine Proteinase Inhibitors/adverse effects ; Serine Proteinase Inhibitors/therapeutic use ; Time Factors ; Treatment Outcome |
| مستخلص: | The ODYSSEY OUTCOMES trial, comprising over 47 000 patient-years of placebo-controlled observation, demonstrated important reductions in the risk of recurrent ischaemic cardiovascular events with the monoclonal antibody to proprotein convertase subtilisin/kexin type 9 alirocumab, as well as lower all-cause death. These benefits were observed in the context of substantial and persistent lowering of low-density lipoprotein cholesterol with alirocumab compared with that achieved with placebo. The safety profile of alirocumab was indistinguishable from matching placebo except for a ∼1.7% absolute increase in local injection site reactions. Further, the safety of alirocumab compared with placebo was evident in vulnerable groups identified before randomization, such as the elderly and those with diabetes mellitus, previous ischaemic stroke, or chronic kidney disease. The frequency of adverse events and laboratory-based abnormalities was generally similar to that in placebo-treated patients. Thus, alirocumab appears to be a safe and effective lipid-modifying treatment over a duration of at least 5 years. (© The Author(s) 2024. Published by Oxford University Press on behalf of the European Society of Cardiology.) |
| References: | Eur Heart J. 2015 May 14;36(19):1186-94. (PMID: 25687353) N Engl J Med. 2017 Aug 17;377(7):633-643. (PMID: 28813214) Lancet. 2017 Oct 28;390(10106):1962-1971. (PMID: 28859947) Lancet Diabetes Endocrinol. 2019 Aug;7(8):618-628. (PMID: 31272931) Lancet. 2016 Nov 19;388(10059):2532-2561. (PMID: 27616593) Cardiovasc Drugs Ther. 2016 Oct;30(5):473-483. (PMID: 27618825) Am Heart J. 2014 Nov;168(5):682-9. (PMID: 25440796) N Engl J Med. 2016 Dec;375(22):2144-2153. (PMID: 27959767) Int J Cardiol. 2014 Sep;176(1):55-61. (PMID: 25037695) J Am Coll Cardiol. 2017 Feb 7;69(5):471-482. (PMID: 28153102) Circulation. 2016 Dec 13;134(24):1931-1943. (PMID: 27777279) Int J Cardiol. 2016 Nov 15;223:750-757. (PMID: 27573600) Circ Cardiovasc Qual Outcomes. 2017 Jan;10(1):. (PMID: 28073851) Eur Heart J. 2016 Feb 7;37(6):536-45. (PMID: 26578202) Diabetes Obes Metab. 2018 Jun;20(6):1479-1489. (PMID: 29436756) N Engl J Med. 2017 Apr 20;376(16):1589-90. (PMID: 28304229) Circulation. 2019 Dec 17;140(25):2054-2062. (PMID: 31707788) Am J Cardiol. 2017 Sep 15;120(6):931-939. (PMID: 28750828) Circulation. 2022 Oct 11;146(15):1109-1119. (PMID: 36031810) Eur Heart J. 2015 Nov 14;36(43):2996-3003. (PMID: 26330422) Eur Heart J. 2019 Sep 1;40(33):2801-2809. (PMID: 31121022) N Engl J Med. 2015 Apr 16;372(16):1489-99. (PMID: 25773378) J Gen Intern Med. 2015 Mar;30(3):348-58. (PMID: 25575908) Diabetes Care. 2021 May;44(5):1219-1227. (PMID: 33722880) Am J Cardiol. 2016 Jul 1;118(1):56-63. (PMID: 27184170) J Am Coll Cardiol. 2020 Jan 21;75(2):133-144. (PMID: 31948641) Am J Cardiol. 2016 Dec 15;118(12):1805-1811. (PMID: 27729106) Am J Cardiol. 2014 Dec 1;114(11):1682-9. (PMID: 25439449) J Am Coll Cardiol. 2012 Jun 19;59(25):2344-53. (PMID: 22463922) N Engl J Med. 2012 Mar 22;366(12):1108-18. (PMID: 22435370) J Clin Lipidol. 2014 Nov-Dec;8(6):554-561. (PMID: 25499937) J Am Coll Cardiol. 2019 Sep 3;74(9):1177-1186. (PMID: 31466614) Atherosclerosis. 2021 Aug;331:20-27. (PMID: 34303265) Lancet. 2010 Feb 27;375(9716):735-42. (PMID: 20167359) Am Heart J. 2015 Jun;169(6):906-915.e13. (PMID: 26027630) N Engl J Med. 2018 Nov 29;379(22):2097-2107. (PMID: 30403574) Eur Heart J. 2020 Nov 21;41(44):4245-4255. (PMID: 33051646) N Engl J Med. 2017 May 4;376(18):1713-1722. (PMID: 28304224) Circulation. 2019 Jul 9;140(2):103-112. (PMID: 31117810) Eur Heart J. 2018 Feb 1;39(5):374-381. (PMID: 29186504) J Am Heart Assoc. 2023 Sep 19;12(18):e029216. (PMID: 37702079) BMC Ophthalmol. 2023 Jun 16;23(1):279. (PMID: 37328736) N Engl J Med. 2012 Nov 15;367(20):1891-900. (PMID: 23113833) J Am Coll Cardiol. 2020 Aug 18;76(7):886-888. (PMID: 32792087) Eur Heart J. 2020 Jun 21;41(24):2248-2258. (PMID: 31732742) Eur Heart J. 2016 Oct 14;37(39):2981-2989. (PMID: 27460890) J Am Coll Cardiol. 2017 May 16;69(19):2468-2469. (PMID: 28494987) Circulation. 2021 Mar 16;143(11):1109-1122. (PMID: 33438437) J Clin Endocrinol Metab. 2015 Aug;100(8):3140-8. (PMID: 26030325) Diabetes Obes Metab. 2017 Dec;19(12):1781-1792. (PMID: 28905478) Lancet. 2012 Jul 7;380(9836):29-36. (PMID: 22633824) J Am Coll Cardiol. 2019 Feb 5;73(4):387-396. (PMID: 30428396) JAMA Cardiol. 2017 May 1;2(5):547-555. (PMID: 28291866) J Am Coll Cardiol. 2019 Sep 3;74(9):1167-1176. (PMID: 30898609) BMJ. 2017 Apr 24;357:j1648. (PMID: 28438747) Circulation. 2023 Apr 18;147(16):1192-1203. (PMID: 36779348) Lancet. 2010 Nov 13;376(9753):1670-81. (PMID: 21067804) Eur Heart J. 2020 Nov 7;41(42):4114-4123. (PMID: 32820320) |
| معلومات مُعتمدة: | Sanofi; Regeneron Pharmaceuticals, Inc. |
| فهرسة مساهمة: | Investigator: GG Schwartz; PG Steg; DL Bhatt; VA Bittner; R Diaz; SG Goodman; RA Harrington; JW Jukema; M Szarek; HD White; AM Zeiher; P Tricoci; MT Roe; KW Mahaffey; JM Edelberg; C Hanotin; G Lecorps; A Moryusef; R Pordy; WJ Sasiela; JF Tamby; R Diaz; PE Aylward; H Drexel; P Sinnaeve; M Dilic; RD Lopes; NN Gotcheva; SG Goodman; JC Prieto; H Yong; P López-Jaramillo; I Pećin; Z Reiner; P Ostadal; SH Poulsen; M Viigimaa; MS Nieminen; N Danchin; V Chumburidze; N Marx; E Liberopoulos; PCM Valdovinos; HF Tse; RG Kiss; D Xavier; D Zahger; M Valgimigli; T Kimura; HS Kim; SH Kim; A Erglis; A Laucevicius; S Kedev; K Yusoff; GAR López; M Alings; HD White; S Halvorsen; RMC Flores; RG Sy; A Budaj; J Morais; M Dorobantu; Y Karpov; AD Ristic; T Chua; J Murin; Z Fras; AJ Dalby; J Tuñón; HA de Silva; E Hagström; U Landmesser; CE Chiang; P Sritara; S Guneri; A Parkhomenko; KK Ray; PM Moriarty; B Chaitman; SF Kelsey; AG Olsson; JL Rouleau; ML Simoons; K Alexander; C Meloni; R Rosenson; EJG Sijbrands; P Tricoci; JH Alexander; L Armaganijan; A Bagai; MC Bahit; JM Brennan; S Clifton; AD DeVore; S Deloatch; S Dickey; K Dombrowski; G Ducrocq; Z Eapen; P Endsley; A Eppinger; RW Harrison; CN Hess; MA Hlatky; JD Jordan; JW Knowles; BJ Kolls; DF Kong; S Leonardi; L Lillis; RD Lopes; DJ Maron; KW Mahaffey; J Marcus; R Mathews; RH Mehta; RJ Mentz; CB Patel; SB Pereira; L Perkins; TJ Povsic; E Puymirat; MT Roe; WS Jones; BR Shah; MW Sherwood; K Stringfellow; D Sujjavanich; M Toma; C Trotter; SFP van Diepen; MD Wilson; AT Yan; LB Schiavi; M Garrido; AF Alvarisqueta; SA Sassone; AP Bordonava; AEA De Lima; JM Schmidberg; EA Duronto; OC Caruso; LP Novaretto; MA Hominal; OR Montaña; A Caccavo; OAG Vilamajo; AJ Lorenzatti; LR Cartasegna; GA Paterlini; IJ Mackinnon; GD Caime; M Amuchastegui; O Salomone; OR Codutti; HO Jure; JOE Bono; AD Hrabar; JA Vallejos; RAA Guerrero; F Novoa; CA Patocchi; CJ Zaidman; ME Giuliano; RD Dran; ML Vico; GS Carnero; PN Guzman; JCM Allende; DFG Brasca; MHB Labarta; S Nani; EDS Blumberg; HR Colombo; A Liberman; V Fuentealba; HL Luciardi; GD Waisman; MA Berli; RO Garcia Duran; HG Cestari; HA Luquez; JA Giordano; SS Saavedra; G Zapata; O Costamagna; S Llois; JH Waites; N Collins; A Soward; PE Aylward; CLS Hii; PE Aylward; J Shaw; MA Arstall; J Horowitz; D Ninio; JF Rogers; D Colquhoun; REO Flores; P Roberts-Thomson; O Raffel; SJ Lehman; C Aroney; SGM Coverdale; PJ Garrahy; G Starmer; M Sader; PA Carroll; R Dick; R Zweiker; U Hoppe; H Drexel; K Huber; R Berger; G Delle-Karth; B Frey; D Faes; K Hermans; B Pirenne; A Leone; E Hoffer; P Sinnaeve; MCM Vrolix; L De Wolf; B Wollaert; M Castadot; K Dujardin; C Beauloye; G Vervoort; H Striekwold; C Convens; J Roosen; E Barbato; M Claeys; F Cools; I Terzic; F Barakovic; Z Midzic; B Pojskic; E Fazlibegovic; M Dilic; A Durak-Nalbantic; M Kulić; D Vulic; A Muslibegovic; B Goronja; G Reis; L Sousa; JC Nicolau; FE Giorgeto; RP Silva; LN Maia; R Rech; PRF Rossi; MJAG Cerqueira; N Duda; R Kalil; A Kormann; JAM Abrantes; PP Filho; AP Soggia; MON de Santos; F Neuenschwander; LC Bodanese; YL Michalaros; FG Eliaschewitz; MH Vidotti; PE Leaes; RV Botelho; S Kaiser; ERFF Manenti; DB Precoma; JCM Jorge; P Silva; JA Silveira; W Saporito; JAM Neto; GS Feitosa; LEF Ritt; JA de Souza; F Costa; WKSB Souza; HJL Reis; RD Lopes; L Machado; JCA Ayoub; GV Todorov; FP Nikolov; ES Velcheva; ML Tzekova; HO Benov; SL Petranov; HS Tumbev; NS Shehova-Yankova; DT Markov; DH Raev; MN Mollov; KN Kichukov; KA Ilieva-Pandeva; NN Gotcheva; R Ivanova; M Gospodinov; VM Mincheva; PV Lazov; BI Dimov; M Senaratne; J Stone; J Kornder; D Dion; D Savard; Y Pesant; A Pandey; S Robinson; G Gosselin; S Vizel; G Hoag; R Bourgeois; A Morisset; E Sabbah; B Sussex; S Kouz; P MacDonald; A Diaz; N Michaud; D Fell; T Vuurmans; C Lai; F Nigro; R Davies; G Nogareda; R Vijayaraghavan; J Ducas; S Lepage; S Mehta; J Cha; R Dupuis; P Fong; S Lutchmedial; J Rodes-Cabau; H Fadlallah; D Cleveland; T Huynh; I Bata; A Hameed; C Pincetti; S Potthoff; JC Prieto; M Acevedo; A Aguirre; M Vejar; M Yañez; G Araneda; M Fernandez; L Perez; P Varleta; F Florenzano; L Huidobro; CA Raffo; C Olivares; L Nahuelpan; H Montecinos; J Chen; Y Dong; W Huang; J Wang; S Huang; Z Yao; X Li; L Cui; W Lin; Y Sun; J Wang; J Li; X Zhang; H Zhu; D Chen; L Huang; S Dong; G Su; B Xu; X Su; X Cheng; J Lin; W Zong; H Li; Y Feng; D Xu; X Yang; Y Ke; X Lin; Z Zhang; Z Zheng; Z Luo; Y Chen; C Ding; Y Zhong; Y Zheng; X Li; D Peng; S Zhao; Y Li; X Liu; M Wei; S Liu; Y Yu; B Qu; W Jiang; Y Zhou; X Zhao; Z Yuan; Y Guo; X Xu; X Shi; J Ge; G Fu; F Bai; W Fang; X Shou; X Yang; J Wang; M Xiang; Y Sun; Q Lu; R Zhang; J Zhu; Y Xu; Z Fan; T Li; C Wu; N Jaramillo; GS Vallejo; DC Luna Botia; RB Lopez; DI Molina De Salazar; AJ Cadena Bonfanti; CC Aroca; JD Higuera; M Blanquicett; SI Barrera Silva; HJG Lozada; JA Coronel Arroyo; JL Accini Mendoza; RLF Ruiz; AM Quintero Ossa; FG Manzur Jatin; AS Herazo; JC Parada; RS Arambula; MAU Triana; AM Fernandez Trujillo; M Strozzi; S Car; M Jerić; ML Benčić; H Pintarić; Đ Prvulović; J Šikić; V Peršić; D Mileta; K Štambuk; Z Babić; V Tomulic; J Lukenda; S Mejic-Krstulovic; B Starcevic; J Spinar; D Horak; Z Velicka; J Stasek; D Alan; V Machova; A Linhart; V Novotny; V Kaucak; R Rokyta; R Naplava; Z Coufal; V Adamkova; I Podpera; J Zizka; Z Motovska; I Marusincova; P Svab; P Ostadal; P Heinc; J Kuchar; P Povolny; J Matuska; SH Poulsen; B Raungaard; P Clemmensen; LE Bang; O May; M Bøttcher; JD Hove; L Frost; G Gislason; J Larsen; PB Johansen; F Hald; P Johansen; J Jeppesen; T Nielsen; KS Kristensen; PM Walichiewicz; JD Lomholdt; IC Klausen; PK Nielsen; F Davidsen; L Videbaek; M Viigimaa; M Soots; V Vahula; A Hedman; Ü Soopõld; K Märtsin; T Jurgenson; A Kristjan; MS Nieminen; H Huikuri; P Coste; E Ferrari; N Danchin; O Morel; G Montalescot; J Machecourt; G Barone-Rochette; J Mansourati; Y Cottin; PG Steg; F Leclercq; A Belhassane; N Delarche; F Boccara; F Paganelli; J Clerc; F Schiele; V Aboyans; V Probst; J Berland; T Lefèvre; B Citron; V Chumburidze; I Khintibidze; T Shaburishvili; Z Pagava; R Ghlonti; Z Lominadze; G Khabeishvili; R Hemetsberger; K Edward; U Rauch-Kröhnert; M Stratmann; KF Appel; E Schmidt; H Omran; C Stellbrink; T Dorsel; E Lianopoulos; HF Vöhringer; R Marx; A Zirlik; D Schellenberg; T Heitzer; U Laufs; C Werner; N Marx; S Gielen; S Nuding; B Winkelmann; S Behrens; K Sydow; M Karakas; G Simonis; T Muenzel; N Werner; S Leggewie; D Böcker; R Braun-Dullaeus; N Toursarkissian; M Jeserich; M Weißbrodt; T Schaeufele; J Weil; H Völler; J Waltenberger; M Natour; S Schmitt; D Müller-Wieland; S Steiner; L Heidenreich; E Offers; U Gremmler; H Killat; W Rieker; S Patsilinakos; A Kartalis; A Manolis; D Sionis; G Chachalis; E Liberopoulos; I Skoumas; V Athyros; P Vardas; F Parthenakis; D Alexopoulos; G Hahalis; J Lekakis; A Hatzitolios; SRF Ovando; PCM Valdovinos; JL Arango Benecke; ER Rodriguez De Leon; BPY Yan; DCW Siu; T Turi; B Merkely; RG Kiss; I Ungi; G Lupkovics; L Nagy; A Katona; I Édes; G Müller; I Horvath; T Kapin; Z Szigeti; J Faluközy; M Kumbla; M Sandhu; S Annam; NR Proddutur; R Regella; RK Premchand; A Mahajan; S Pawar; AD Abhyanakar; P Kerkar; RA Govinda; A Oomman; D Sinha; SN Patil; D Kahali; J Sawhney; AB Joshi; S Chaudhary; P Harkut; S Guha; S Porwal; S Jujjuru; RB Pothineni; MR Monteiro; A Khan; SS Iyengar; JS Grewal; M Chopda; MC Fulwani; DA Patange; P Sachin; VK Chopra; NK Goyal; R Shinde; GV Manakshe; N Patki; S Sethi; V Munusamy; SKS Thanvi; S Adhyapak; C Patil; U Pandurangi; R Mathur; J Gupta; S Kalashetti; A Bhagwat; B Raghuraman; SK Yerra; P Bhansali; R Borse; P Rahul; S Das; V Kumar; J Abdullakutty; S Saathe; P Palimkar; J Abdullkutty; S Sathe; S Atar; M Shechter; M Mosseri; Y Arbel; C Ehud; H Ofer; C Lotan; U Rosenschein; A Katz; Y Henkin; A Francis; M Klutstein; E Nikolsky; R Zukermann; Y Turgeman; M Halabi; A Marmor; R Kornowski; M Jonas; O Amir; Y Hasin; Y Rozenman; S Fuchs; V Zvi; O Hussein; D Gavish; Z Vered; Y Caraco; M Elias; N Tov; E Wolfovitz; M Lishner; N Elias; G Piovaccari; A De Pellegrin; R Garbelotto; G Guardigli; V Marco; G Licciardello; C Auguadro; F Scalise; C Cuccia; A Salvioni; G Musumeci; M Senni; P Calabrò; S Novo; P Faggiano; M Metra; NB De Cesare; S Berti; C Cavallini; E Puccioni; M Galvani; M Tespili; P Piatti; M Palvarini; G De Luca; R Violini; A De Leo; Z Olivari; PP Filardi; M Ferratini; V Racca; K Dai; Y Shimatani; H Kamiya; K Ando; Y Takeda; Y Morino; Y Hata; K Kimura; K Kishi; I Michishita; H Uehara; T Higashikata; A Hirayama; K Hirooka; Y Doi; S Sakagami; S Taguchi; A Koike; H Fujinaga; S Koba; K Kozuma; T Kawasaki; Y Ono; M Shimizu; Y Katsuda; A Wada; T Shinke; T Kimura; J Ako; K Fujii; T Takahashi; T Sakamoto; K Nakao; Y Furukawa; H Sugino; R Tamura; T Mano; M Uematsu; N Utsu; K Ito; T Haraguchi; K Sato; Y Ueda; A Nishibe; K Fujimoto; M Masutani; A Nishibe; K Fujimoto; JH Yoon; SH Kim; HL Kim; HS Park; IH Chae; MH Kim; MH Jeong; S Rha; C Kim; HS Kim; HY Kim; T Hong; SJ Tahk; Y Kim; A Busmane; N Pontaga; A Strelnieks; I Mintale; I Sime; Z Petrulioniene; R Kavaliauskiene; R Jurgaitiene; G Sakalyte; R Slapikas; S Norkiene; N Misonis; A Kibarskis; R Kubilius; S Bojovski; S Kedev; N Lozance; A Kjovkaroski; S Doncovska; TK Ong; S Kasim; O Maskon; B Kandasamy; K Yusoff; HB Liew; WMIW Mohamed; AG Castillo; GAR López; JC Calvillo; PF Campos; JCN Fragoso; EAB Llamas; MAA Gamba; JC Madrigal; LGG Salas; EL Rosas; BG Díaz; ES Vázquez; AN Ackar; GAL Esperón; CRM Sánchez; MG De Leon; RS Otero; GF Salmón; JAP Ríos; JAG Ruíz; M Alings; RW Breedveld; M Feenema-Aardema; A Borger-Van Der Burg; PAM Hoogslag; H Suryapranata; A Oomen; P Van Haelst; M Feenema-Aradema; JJ Wiersma; D Basart; RMA Van Der Wal; P Zwart; P Monraats; H Van Kesteren; I Karalis; J Jukema; GJE Verdel; BRG Brueren; RPTH Troquay; EP Viergever; NYY Al-Windy; GL Bartels; JH Cornel; WRM Hermans; JPR Herrman; RJ Bos; RGEJ Groutars; CC Van Der Zwaan; R Kaplan; R Lionarons; E Ronner; BE Groenemeijer; PNA Bronzwaer; AAH Liem; BJWM Rensing; MJJA Bokern; R Nijmeijer; FMRJ Hersbach; FF Willems; ATM Gosselink; S Rasoul; J Elliott; G Wilkins; R Fisher; D Scott; H Hart; R Stewart; S Harding; I Ternouth; N Fisher; S Wilson; D Aitken; R Anscombe; L Davidson; T Tomala; O Nygård; JA Sparby; K Andersen; L Gullestad; J Jortveit; PS Munk; EG Singsaas; S Halvorsen; U Hurtig; RM Correa Flores; JR Calderon Ticona; JRD Velasquez; SAN Miguel; ESS Perez; JM Carrion Chambilla; CA Chavez Ayala; RPC Leon; RJ Vargas Gonzales; JD Hernandez Zuniga; LAC Cosavalente; JE Bravo Mannucci; JH Landeo; NC Llerena Navarro; YMR Concha; VE Rodriguez Chavez; HA Anchante Hernandez; CA Zea Nunez; WM Ramos; A Ferrolino; RAG Sy; L Tirador; RG Sy; G Matiga; RM Coching; A Bernan; G Rogelio; DD Morales; E Tan; DJ Sulit; A Wlodarczak; K Jaworska; G Skonieczny; L Pawlowicz; P Wojewoda; B Busz-Papiez; J Bednarski; A Goch; P Staneta; E Dulak; A Budaj; K Saminski; W Krasowski; W Sudnik; A Zurakowski; M Skorski; R Lysek; B Miklaszewicz; J Kubica; JA Lipko; E Kostarska-Srokosz; M Piepiorka; A Drzewiecka; R Sciborski; A Stasiewski; T Blicharski; L Bystryk; M Szpajer; M Korol; T Czerski; E Mirek-Bryniarska; J Gniot; A Lubinski; J Gorny; E Franek; G Raczak; H Szwed; P Monteiro; JM Bastos; HH Pereira; D Martins; J Morais; F Seixo; C Mendonça; A Botelho; F Caetano; B Minescu; O Istratoaie; DN Tesloianu; M Dorobantu; G Cristian; S Dumitrescu; CGC Podoleanu; MCA Constantinescu; CM Bengus; C Militaru; D Rosu; IR Parepa; AV Matei; TM Alexandru; M Malis; I Coman; R Stanescu-Cioranu; D Dimulescu; Y Shvarts; O Orlikova; Z Kobalava; OL Barbarash; V Markov; N Lyamina; A Gordienko; K Zrazhevsky; AY Vishnevsky; V Gurevich; R Stryuk; NV Lomakin; I Bokarev; T Khlevchuk; S Shalaev; L Khaisheva; P Chizhov; I Viktorova; N Osokina; V Shchekotov; E Akatova; G Chumakova; I Libov; MI Voevoda; TV Tretyakova; E Baranov; S Shustov; S Yakushin; I Gordeev; N Khasanov; O Reshetko; T Sotnikova; O Molchanova; K Nikolaev; L Gapon; E Baranova; Z Shogenov; E Kosmachova; Y Karpov; Y Karpov; A Povzun; L Egorova; VV Tyrenko; IG Ivanov; M Ilya; S Kanorsky; D Simic; N Ivanovic; G Davidovic; N Tasic; MR Asanin; S Stojic; SR Apostolovic; S Ilic; BP Tosic; A Stankovic; A Arandjelovic; S Radovanovic; B Todic; AD Ristic; J Balinovac; DV Dincic; P Seferovic; A Karadzic; S Dodic; S Dimkovic; T Jakimov; T Chua; KK Poh; HY Ong; J Tang I-Shing; K Micko; J Nociar; D Pella; P Fulop; M Hranai; J Palka; J Mazur; I Majercák; A Dzupina; F Fazekas; J Gonsorcik; V Bugan; J Murin; J Selecky; G Kamensky; J Strbova; R Smik; A Dukat; P Olexa; I Žuran; J Poklukar; NČ Šuligoj; M Cevc; Z Fras; HP Cyster; N Ranjith; C Corbett; J Bayat; EM Makotoko; H du Toit Theron; IE Kapp; MM de V Basson; H Lottering; D Van Aswegen; LJ Van Zyl; PJ Sebastian; T Pillay; JA Saaiman; PJ Commerford; S Cassimjee; G Riaz; IO Ebrahim; M Sarvan; JH Mynhardt; AJ Dalby; H Reuter; R Moodley; M Vida; AR Cequier Fillat; VB Peris; FF Jimenez; F Marín; JMC Fernández; RJH Urbano; B Gil-Extremera; P Toledo; FW Diz; D Garcia-Dorado; A Iñiguez; JT Fernández; JR Gonzalez-Juanatey; JF Portales; FC Murillo; LM Pericas; JL Zamorano; MM Martin; JB Cortada; JJ Alonso Martin; JMS Antolin; JR De Berrazueta Fernández; JAV de Prada; JFD Fernández; JAG Lledó; JC Sales; JB Rodriguez; GG Tragant; A Benedicto; C Gonzalez-Juanatey; MC Potau; IP Perez; CM De La Tassa; PL Rincon; JB Recena; JM Escudier; AC Payeras; NA Orcajo; P Valdivielso; G Constantine; R Haniffa; N Tissera; S Amarasekera; C Ponnamperuma; N Fernando; K Fernando; J Jayawardena; S Wijeyasingam; G Ranasinghe; R Ekanayaka; S Mendis; V Senaratne; G Mayurathan; A Rajapaksha; T Sirisena; JI Herath; N Amarasena; S Berglund; G Rasmanis; E Hagström; O Vedin; N Witt; G Mourtzinis; P Nicol; O Hansen; S Romeo; SA Jensen; I Torstensson; U Ahremark; T Sundelin; T Moccetti; C Müller; F Mach; R Binde; U Landmesser; O Gämperli; CE Chiang; WC Tsai; KC Ueng; WT Lai; ME Liu; JJ Hwang; WH Yin; IC Hsieh; MJ Hsieh; WH Lin; JY Kuo; TY Huang; CY Fang; P Kaewsuwanna; W Soonfuang; W Jintapakorn; A Sukonthasarn; P Sritara; N Wongpraparut; K Sastravaha; N Sansanayudh; W Kehasukcharoen; D Piyayotai; P Chotnoparatpat; A Camsari; H Kultursay; S Guneri; B Mutlu; M Ersanli; M Demirtas; C Kirma; E Ural; L Koldas; O Karpenko; A Prokhorov; I Vakaluyk; H Myshanych; D Reshotko; V Batushkin; L Rudenko; I Kovalskyi; M Kushnir; V Tseluyko; Y Mostovoy; M Stanislavchuk; Y Kyiak; Y Karpenko; Y Malynovsky; A Klantsa; O Kutniy; E Amosova; V Tashchuk; O Leshchuk; A Parkhomenko; M Rishko; M Kopytsya; A Yagensky; M Vatutin; A Bagriy; OM Barna; O Ushakov; G Dzyak; B Goloborodko; A Rudenko; V Zheleznyy; J Trevelyan; A Zaman; K Lee; A Moriarty; RK Aggarwal; P Clifford; YK Wong; SMR Iqbal; E Subkovas; D Braganza; D Sarkar; R Storey; H Griffiths; S Mcclure; R Muthusamy; S Smith; J Kurian; T Levy; C Barr; H Kadr; R Gerber; A Simaitis; H Soran; A Mathur; A Brodison; M Ayaz; M Cheema; R Oliver; S Thackray; T Mudawi; G Rahman; A Sultan; T Reynolds; D Sharman; D Sprigings; R Butler; P Wilkinson; GYH Lip; J Halcox; S Gallagher; N Ossei-Gerning; G Vardi; D Baldari; D Brabham; C Treasure; C Dahl; B Palmer; A Wiseman; A Khan; S Puri; AE Mohart; C Ince; E Flores; S Wright; SC Cheng; M Rosenberg; W Rogers; E Kosinski; L Forgosh; J Waltman; M Khan; M Shoukfeh; G Dagher; P Cambier; I Lieber; P Kumar; C East; P Krichmar; M Hasan; L White; T Knickelbine; T Haldis; E Gillespie; T Amidon; D Suh; I Arif; M Abdallah; F Akhter; E Carlson; M D'Urso; F El-Ahdab; W Nelson; K Moriarty; B Harris; S Cohen; L Carter; D Doty; K Sabatino; T Haddad; A Malik; S Rao; A Mulkay; I Jovin; K Klancke; V Malhotra; SK Devarapalli; M Koren; H Chandna; G Dodds; T Goraya; J Bengston; M Janik; J Moran; A Sumner; J Kobayashi; W Davis; S Yazdani; J Pasquini; M Thakkar; A Vedere; W Leimbach; J Rider; S Fenton; N Singh; AV Shah; PM Moriarty; D Janosik; C Pepine; B Berman; J Gelormini; C Daniels; K Richard; F Keating; NI Kondo; S Shetty; H Levite; W Waider; T Takata; M Abu-Fadel; V Shah; R Aggarwal; M Izzo; A Kumar; B Hattler; R Do; C Link; A Bortnick; G Kinzfogl; A Ghitis; J Larry; E Teufel; P Kuhlman; B Mclaurin; W Zhang; S Thew; J Abbas; M White; O Islam; S Subherwal; N Ranadive; B Vakili; C Gring; D Henderson; T Schuchard; N Farhat; G Kline; S Mahal; J Whitaker; S Speirs; R Andersen; N Daboul; P Horwitz; F Zahr; G Ponce; Z Jafar; J Mcgarvey; V Panchal; S Voyce; T Blok; W Sheldon; MM Azizad; C Schmalfuss; M Picone; R Pederson; W Herzog; K Friedman; J Lindsey; R Nowins; E Timothy; P Leonard; N Lepor; M El Shahawy; H Weintraub; A Irimpen; A Alonso; W May; D Christopher; T Galski; A Chu; F Mody; E Ramin; Z Hodes; J Rossi; G Rose; J Fairlamb; C Lambert; A Raisinghani; A Abbate; G Vetrovec; M King; C Carey; J Gerber; L Younis; HT Park; M Vidovich; T Knutson; D Friedman; F Chaleff; A Loussararian; P Rozeman; C Kimmelstiel; J Kuvin; K Silver; M Foster; G Tonnessen; A Espinoza; M Amlani; A Wali; C Malozzi; GT Jong; C Massey; K Wattanakit; PJ O'Donnell; D Singal; N Jaffrani; S Banuru; D Fisher; M Xenakis; N Perlmutter; R Bhagwat; J Strader; R Blonder; A Akyea-Djamson; A Labroo; K Lee; HJ Marais; E Claxton; R Weiss; R Kathryn; M Berk; P Rossi; P Joshi; A Khera; AS Khaira; G Kumkumian; S Lupovitch; J Purow; S Welka; D Hoffman; S Fischer; E Soroka; D Eagerton; S Pancholy; M Ray; N Erenrich; M Farrar; S Pollock; WJ French; S Diamantis; D Guy; L Gimple; M Neustel; S Schwartz; E Pereira; S Albert; D Spriggs; J Strain; S Mittal; A Vo; M Chane; J Hall; N Vijay; K Lotun; FM Lester; A Nahhas; T Pope; P Nager; R Vohra; M Sharma; R Bashir; H Ahmed; M Berlowitz; R Fishberg; R Barrucco; E Yang; M Radin; D Sporn; D Stapleton; S Eisenberg; J Landzberg; M Mcgough; S Turk; M Schwartz; PS Sundram; D Jain; M Zainea; C Bayron; R Karlsberg; S Dohad; H Lui; W Keen; D Westerhausen; S Khurana; H Agarwal; J Birchem; W Penny; M Chang; S Murphy; J Henry; B Schifferdecker; JM Gilbert; G Chalavarya; C Eaton; JF Schmedtje; S Christenson; I Dotani; D Denham; A Macdonell; P Gibson; A Rahman; TA Joundi; N Assi; G Conrad; P Kotha; M Love; G Giesler; H Rubenstein; D Gamil; L Akright; J Krawczyk; J Cobler; T Wells; J Welker; R Foster; R Gilmore; J Anderson; D Jacoby; B Harris; G Gardner; R Dandillaya; K Vora; J Kostis; J Hunter; D Laxson; E Ball; J Anderson; T Wells; K Vora; E Ball; J Welker; RD Lopes; F Egydio; A Kawakami; J Oliveira; SG Goodman; J Wozniak; A Matthews; C Ratky; J Valiris; L Berdan; A Hepditch; K Quintero; MT Roe; T Rorick; M Westbrook; R Diaz; A Pascual; C Rovito; N Danchin; M Bezault; E Drouet; T Simon; HD White; C Alsweiler; P Sinnaeve; A Luyten; PE Aylward; J Butters; L Griffith; M Shaw; E Hagström; L Grunberg; M Szarek; S Islam; MF Brégeault; N Bougon; D Faustino; S Fontecave; J Murphy; JF Tamby; M Verrier; V Agnetti; D Andersen; E Badreddine; M Bekkouche; C Bouancheau; I Brigui; M Brocklehurst; J Cianciarulo; D Devaul; S Domokos; C Gache; C Gobillot; S Guillou; J Healy; M Heath; G Jaiwal; C Javierre; J Labeirie; M Monier; U Morales; A Mrabti; B Mthombeni; B Okan; L Smith; J Sheller; S Sopena; V Pellan; F Benbernou; N Bengrait; M Lamoureux; K Kralova; M Scemama; R Bejuit; A Coulange; C Berthou; J Repincay; C Lorenzato; A Etienne; V Gouet; G Lecorps; V Loizeau; M Normand; A Ourliac; C Rondel; A Adamo; P Beltran; P Barraud; H Dubois-Gache; B Halle; L Metwally; M Mourgues; M Sotty; M Vincendet; R Cotruta; Z Chengyue; D Fournie-Lloret; C Morrello; A Perthuis; P Picault; I Zobouyan; HM Colhoun; MA Dempsey; MA McClanahan Keywords: Alirocumab; Cholesterol; PCSK9; Safety |
| المشرفين على المادة: | PP0SHH6V16 (alirocumab) 0 (Antibodies, Monoclonal, Humanized) 0 (Anticholesteremic Agents) 0 (Biomarkers) 0 (Cholesterol, LDL) 0 (PCSK9 Inhibitors) EC 3.4.21.- (PCSK9 protein, human) EC 3.4.21.- (Proprotein Convertase 9) 0 (Serine Proteinase Inhibitors) |
| تواريخ الأحداث: | Date Created: 20240424 Date Completed: 20240716 Latest Revision: 20240718 |
| رمز التحديث: | 20240718 |
| مُعرف محوري في PubMed: | PMC11249957 |
| DOI: | 10.1093/ehjcvp/pvae025 |
| PMID: | 38658193 |
| قاعدة البيانات: | MEDLINE |
| تدمد: | 2055-6845 |
|---|---|
| DOI: | 10.1093/ehjcvp/pvae025 |